Your browser doesn't support javascript.
loading
Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair.
Abeykoon, Jithma P; Wu, Xiaosheng; Nowakowski, Kevin E; Dasari, Surendra; Paludo, Jonas; Weroha, S John; Hu, Chunling; Hou, Xiaonan; Sarkaria, Jann N; Mladek, Ann C; Phillips, Jessica L; Feldman, Andrew L; Ravindran, Aishwarya; King, Rebecca L; Boysen, Justin; Stenson, Mary J; Carr, Ryan M; Manske, Michelle K; Molina, Julian R; Kapoor, Prashant; Parikh, Sameer A; Kumar, Shaji; Robinson, Steven I; Yu, Jia; Boughey, Judy C; Wang, Liewei; Goetz, Matthew P; Couch, Fergus J; Patnaik, Mrinal M; Witzig, Thomas E.
Affiliation
  • Abeykoon JP; Division of Hematology, Department of Internal Medicine.
  • Wu X; Division of Hematology, Department of Internal Medicine.
  • Nowakowski KE; Division of Hematology, Department of Internal Medicine.
  • Dasari S; Department of Health Sciences Research.
  • Paludo J; Division of Hematology, Department of Internal Medicine.
  • Weroha SJ; Department of Oncology.
  • Hu C; Department of Laboratory Medicine and Pathology.
  • Hou X; Department of Oncology.
  • Sarkaria JN; Department of Oncology.
  • Mladek AC; Department of Oncology.
  • Phillips JL; Department of Laboratory Medicine and Pathology.
  • Feldman AL; Department of Laboratory Medicine and Pathology.
  • Ravindran A; Division of Hematopathology, Department of Laboratory Medicine and Pathology, and.
  • King RL; Division of Hematopathology, Department of Laboratory Medicine and Pathology, and.
  • Boysen J; Division of Hematology, Department of Internal Medicine.
  • Stenson MJ; Division of Hematology, Department of Internal Medicine.
  • Carr RM; Department of Oncology.
  • Manske MK; Division of Hematology, Department of Internal Medicine.
  • Molina JR; Department of Oncology.
  • Kapoor P; Division of Hematology, Department of Internal Medicine.
  • Parikh SA; Division of Hematology, Department of Internal Medicine.
  • Kumar S; Division of Hematology, Department of Internal Medicine.
  • Robinson SI; Department of Oncology.
  • Yu J; Department of Oncology.
  • Boughey JC; Department of Surgery, Mayo Clinic, Rochester, MN.
  • Wang L; Department of Oncology.
  • Goetz MP; Department of Oncology.
  • Couch FJ; Department of Health Sciences Research.
  • Patnaik MM; Department of Laboratory Medicine and Pathology.
  • Witzig TE; Division of Hematology, Department of Internal Medicine.
Blood ; 137(4): 513-523, 2021 01 28.
Article in En | MEDLINE | ID: mdl-33507295

Full text: 1 Database: MEDLINE Main subject: Triazoles / Lymphoma, Non-Hodgkin / Antineoplastic Combined Chemotherapy Protocols / Salicylates / Choline / Receptors, Cytoplasmic and Nuclear / Karyopherins / DNA Repair / S Phase Cell Cycle Checkpoints / Hydrazines Type of study: Clinical_trials Language: En Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Main subject: Triazoles / Lymphoma, Non-Hodgkin / Antineoplastic Combined Chemotherapy Protocols / Salicylates / Choline / Receptors, Cytoplasmic and Nuclear / Karyopherins / DNA Repair / S Phase Cell Cycle Checkpoints / Hydrazines Type of study: Clinical_trials Language: En Year: 2021 Type: Article